Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma | MicrobiomeTrials← Back to trialsNCT05561595
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-10-03Est. Completion: 2026-12-31
Enrollment target: 195 participants Locations- University of Florida, Gainesville, Florida, United States
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Obesity
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United StatesCompleted Feb 1, 2025
Type 2 Diabetes Mellitus (T2DM)
Obesity (Disorder)
Overweight
Metabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026